Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Reunited and It Feels So Good: After the Success of Serial Biotech Duo Launches February 8, 2017 Why These 3 Drugmakers Could Buy Incyte April 11, 2017 <b>Norbert Oppitz</b> Joins Sobi As New Senior Vice President, Specialty Care October 5, 2017
